Acertara Acoustic Laboratories, an independent ISO/IEC 17025:2005 accredited medical ultrasound acoustic measurement, testing, and calibration laboratory, and ISO13485:2003 certified probe repair and new product development facility announces that its research and development team has been awarded United States patent #9,983,175 related to a device used for testing diagnostic ultrasound probes.
“This patent represents the 43rd patent our R&D team has been awarded related to diagnostic ultrasound system and probe testing devices. Our engineering team first developed the modern ultrasound probe testing paradigm more than 20 years ago when we introduced FirstCall at Sonora Medical Systems,” Acertara President and CEO G. Wayne Moore said. “It is our passion to continue redesigning the probe testing market by creating disruptive technologies that match the very complex and sophisticated ultrasound probes being used today, including 2D matrix arrays, single crystal arrays, and cMUT arrays. Our team is focused on the continuing challenge of taking our test equipment product development legacy to the next level and creating products that insure the safety and efficacy of ultrasound probes and systems for our most important customers – patients.”
“We have already made significant strides in that area by our introduction of the Aureon and ATLAS devices, both of which have patents issued as well as multiple patents pending,” he added.
The research and development team at Acertara Acoustic Laboratories has been awarded more than 40 U.S. and international patents for productas ranging from 3D ultrasound devices and complex test devices to devices that deliver super-saturated levels of oxygen to the myocardial tissue of heart attack patients.